民祥医药 (834738.OC)

+ 收藏

利润表(民祥医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年中报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 187,321,312.15365,565,389.05243,652,079.77147,547,951.4847,184,805.95
 营业收入(元) 187,321,312.15365,565,389.05243,652,079.77147,547,951.4847,184,805.95
二、营业总成本(元) 174,596,832.41349,178,652.27234,075,025.91142,125,819.8253,331,710.13
 营业成本(元) 137,565,733.72282,152,406.09188,330,263.62110,917,986.7837,665,611.08
 研发费用(元) 11,149,068.3919,821,308.9914,909,709.669,581,679.454,666,417.11
 营业税金及附加(元) 1,488,994.182,533,466.911,306,304.561,251,047.0726,152.03
 销售费用(元) 1,913,978.133,781,553.562,870,692.391,640,970.981,081,052.05
 管理费用(元) 19,185,388.4832,859,056.9523,111,532.5214,630,224.107,701,576.32
 财务费用(元) 3,293,669.518,030,859.773,546,523.164,103,911.442,190,901.54
  其中:利息费用(元) 4,425,613.9010,995,127.6810,361,748.065,333,119.192,010,612.55
  其中:利息收入(元) 45,960.98105,142.8397,508.2076,970.6441,612.51
三、其他经营收益
 资产处置收益(元) -10,989.34-7,880.25-87,471.18-5,004.14-5,048.97
 资产减值损失(元) 1,005,500.61-1,005,500.61---
 信用减值损失(元) 199,683.17-470,182.76-633,854.71270,476.27492,759.28
 其他收益(元) 590,780.312,448,830.351,837,045.881,530,219.41390,327.56
四、营业利润(元) 14,509,454.4917,352,003.5110,692,773.857,217,823.20-5,268,866.31
 加:营业外收入(元) -30,381.0230,381.0230,380.50-
 减:营业外支出(元) 495,310.62132,864.30220,240.7411,132.811.09
五、利润总额(元) 14,014,143.8717,249,520.2310,502,914.137,237,070.89-5,268,867.40
 减:所得税费用(元) 2,060,363.95-1,381,549.982,449,885.111,406,247.78159,167.81
六、净利润(元) 11,953,779.9218,631,070.218,053,029.025,830,823.11-5,428,035.21
(一)按经营持续性分类
  持续经营净利润(元) 11,953,779.9218,631,070.218,053,029.025,830,823.11-5,428,035.21
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 11,953,779.9218,631,070.218,053,029.025,830,823.11-5,428,035.21
 扣除非经常性损益后的净利润(元) 11,881,971.6216,643,373.41-4,385,130.16-5,755,521.08
七、每股收益
 一、基本每股收益(元) 0.090.160.070.05-0.05
 二、稀释每股收益(元) 0.090.160.070.05-0.05
九、综合收益总额(元) 11,953,779.9218,631,070.218,053,029.025,830,823.11-5,428,035.21
 归属于母公司所有者的综合收益总额(元) 11,953,779.9218,631,070.218,053,029.025,830,823.11-5,428,035.21
公告日期 2023-08-252023-04-112023-01-182022-08-262022-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院